<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The present study aimed to evaluate the validity of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnoses and <z:hpo ids='HP_0011420'>death</z:hpo> recording in a primary care database compared with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry (CR) data in England </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The eligible cohort comprised 42,556 participants, registered with English general practices in the General Practice Research Database (GPRD) that consented to CR linkage </plain></SENT>
<SENT sid="2" pm="."><plain>CR and primary care records were compared for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis, date of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Read and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> code sets were reviewed and agreed by two authors </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: There were 5216 (91% of CR total) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> events diagnosed in both sources </plain></SENT>
<SENT sid="5" pm="."><plain>There were 494 (9%) diagnosed in CR only and 213 (4%) that were diagnosed in GPRD only </plain></SENT>
<SENT sid="6" pm="."><plain>The predictive value of a GPRD <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis was 96% for <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, 92% for <z:e sem="disease" ids="C0751571" disease_type="Neoplastic Process" abbrv="">urinary tract cancer</z:e>, 96% for gastro-<z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> and 98% for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>. 'False negative' primary care records were sometimes accounted for by registration end dates being shortly before <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis dates </plain></SENT>
<SENT sid="7" pm="."><plain>The date of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis was median 11 (interquartile range -6 to 30) days later in GPRD compared with CR </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011420'>Death</z:hpo> records were consistent for the two sources for 3337/3397 (99%) of cases </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Recording of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis and mortality in primary care electronic records is generally consistent with CR in England </plain></SENT>
<SENT sid="10" pm="."><plain>Linkage studies must pay careful attention to selection of codes to define eligibility and timing of diagnoses in relation to beginning and end of record </plain></SENT>
</text></document>